These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8573967)

  • 21. How molecular interactions affect crystal morphology: the case of haloperidol.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2011 Nov; 100(11):4896-906. PubMed ID: 21656519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
    Stiles ML; Allen LV; Prince SJ; Holland JS
    Am J Hosp Pharm; 1994 Feb; 51(4):514-7. PubMed ID: 8017420
    [No Abstract]   [Full Text] [Related]  

  • 23. Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
    Benvegnú DM; Barcelos RC; Boufleur N; Reckziegel P; Pase CS; Ourique AF; Beck RC; Bürger ME
    Eur J Pharm Biopharm; 2011 Feb; 77(2):332-6. PubMed ID: 21168486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.
    Katare YK; Daya RP; Sookram Gray C; Luckham RE; Bhandari J; Chauhan AS; Mishra RK
    Mol Pharm; 2015 Sep; 12(9):3380-8. PubMed ID: 26226403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells.
    Sánchez-Wandelmer J; Hernández-Pinto AM; Cano S; Dávalos A; de la Peña G; Puebla-Jiménez L; Arilla-Ferreiro E; Lasunción MA; Busto R
    J Neurochem; 2009 Jul; 110(2):631-40. PubMed ID: 19457089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone and ondansetron incompatibility in polypropylene syringes.
    Brousseau P; Nickerson J; Dobson G
    Can J Anaesth; 2007 Nov; 54(11):953-4. PubMed ID: 17975246
    [No Abstract]   [Full Text] [Related]  

  • 27. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
    Negro S; Reyes R; Azuara ML; Sánchez Y; Barcia E
    Int J Pharm; 2006 Jan; 307(2):278-84. PubMed ID: 16297583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid stabilization at home.
    Reding KM; Reding GR
    Can J Psychiatry; 1996 Nov; 41(9):605-6. PubMed ID: 8946089
    [No Abstract]   [Full Text] [Related]  

  • 31. New data on lithium and haloperidol incompatibility.
    Spring G; Frankel M
    Am J Psychiatry; 1981 Jun; 138(6):818-21. PubMed ID: 6113770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility of paraldehyde with plastic syringes and needle hubs.
    Johnson CE; Vigoreaux JA
    Am J Hosp Pharm; 1984 Feb; 41(2):306-8. PubMed ID: 6702838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 34. ["More is less": a retrospective study of haloperidol dosages in acute schizophrenia].
    Müller R; Kissling W; Kockott G
    Psychiatr Prax; 2000 Mar; 27(2):69-73. PubMed ID: 10738736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics.
    Chiles JA
    Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
    Mali'n TJ; Weidolf L; Castagnoli N; Jurva U
    Rapid Commun Mass Spectrom; 2010 May; 24(9):1231-40. PubMed ID: 20391593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incompatibility of contrast agents with intravascular medications. Work in progress.
    Irving HD; Burbridge BE
    Radiology; 1989 Oct; 173(1):91-2. PubMed ID: 2781036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant hyperthermia caused by neuroleptics].
    Escolano Villén F; Aguilar Sánchez JL; Castrillo Ferrando A; Beser Gascón P; Sabaté Pes A; Campos Suárez JM; Villar Landeira JM
    Rev Esp Anestesiol Reanim; 1985; 32(4):189-91. PubMed ID: 2864723
    [No Abstract]   [Full Text] [Related]  

  • 40. Pleural fluid eosinophilia with combined pharmacotherapy.
    Chiles C; van Wattum PJ
    Psychosomatics; 2003; 44(5):436-7. PubMed ID: 12954922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.